NCT03618654 2025-05-15Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell CarcinomaThomas Jefferson UniversityPhase EARLY_PHASE1 Completed38 enrolled
NCT03132467 2024-06-05Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast CancerM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Completed16 enrolled 8 charts